Correlation Between Edgewise Therapeutics and Third Harmonic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Third Harmonic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Third Harmonic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Third Harmonic Bio, you can compare the effects of market volatilities on Edgewise Therapeutics and Third Harmonic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Third Harmonic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Third Harmonic.

Diversification Opportunities for Edgewise Therapeutics and Third Harmonic

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Edgewise and Third is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Third Harmonic Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Third Harmonic Bio and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Third Harmonic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Third Harmonic Bio has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Third Harmonic go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Third Harmonic

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Third Harmonic. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 2.54 times less risky than Third Harmonic. The stock trades about -0.12 of its potential returns per unit of risk. The Third Harmonic Bio is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  1,307  in Third Harmonic Bio on August 25, 2024 and sell it today you would lose (60.00) from holding Third Harmonic Bio or give up 4.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Edgewise Therapeutics  vs.  Third Harmonic Bio

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Third Harmonic Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Third Harmonic Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Third Harmonic is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Edgewise Therapeutics and Third Harmonic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and Third Harmonic

The main advantage of trading using opposite Edgewise Therapeutics and Third Harmonic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Third Harmonic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Third Harmonic will offset losses from the drop in Third Harmonic's long position.
The idea behind Edgewise Therapeutics and Third Harmonic Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation